» Articles » PMID: 20875075

Trypanosoma Cruzi Infection Induces a Massive Extrafollicular and Follicular Splenic B-cell Response Which is a High Source of Non-parasite-specific Antibodies

Overview
Journal Immunology
Date 2010 Sep 30
PMID 20875075
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Acute infection with Trypanosoma cruzi, the aetiological agent of Chagas' disease, results in parasitaemia and polyclonal lymphocyte activation. It has been reported that polyclonal B-cell activation is associated with hypergammaglobulinaemia and delayed parasite-specific antibody response. In the present study we analysed the development of a B-cell response within the different microenvironments of the spleen during acute T. cruzi infection. We observed massive germinal centre (GC) and extrafollicular (EF) responses at the peak of infection. However, the EF foci were evident since day 3 post-infection (p.i.), and, early in the infection, they mainly provided IgM. The EF foci response reached its peak at 11 days p.i. and extended from the red pulp into the periarteriolar lymphatic sheath. The GCs were detected from day 8 p.i. At the peak of parasitaemia, CD138(+) B220(+) plasma cells in EF foci, red pulp and T-cell zone expressed IgM and all the IgG isotypes. Instead of the substantial B-cell response, most of the antibodies produced by splenic cells did not target the parasite, and parasite-specific IgG isotypes could be detected in sera only after 18 days p.i. We also observed that the bone marrow of infected mice presented a strong reduction in CD138(+) B220(+) cells compared with that of normal mice. Hence, in acute infection with T. cruzi, the spleen appears to be the most important lymphoid organ that lodges plasma cells and the main producer of antibodies. The development of a B-cell response during T. cruzi infection shows features that are particular to T. cruzi and other protozoan infection but different to other infections or immunization with model antigens.

Citing Articles

Control of myeloid-derived suppressor cell dynamics potentiates vaccine protection in multiple mouse models of infection.

Borgna E, Prochetto E, Gamba J, Vermeulen E, Poncini C, Cribb P Front Immunol. 2024; 15:1484290.

PMID: 39555082 PMC: 11568482. DOI: 10.3389/fimmu.2024.1484290.


Signatures of CD4 T and B cells are associated with distinct stages of chronic chagasic cardiomyopathy.

do Vale I, Almeida G, Rimkute I, Liechti T, de Araujo F, Dos Santos L Front Immunol. 2024; 15:1385850.

PMID: 38726014 PMC: 11079136. DOI: 10.3389/fimmu.2024.1385850.


The End Justifies the Means: Chagas Disease from a Perspective of the Host- Interaction.

Volpato Rossi I, de Souza D, Ramirez M Life (Basel). 2024; 14(4).

PMID: 38672758 PMC: 11050810. DOI: 10.3390/life14040488.


Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic infection.

Masip Y, Caeiro L, Cosenza M, Postan M, Molina G, Taboga O Front Cell Infect Microbiol. 2024; 14:1297321.

PMID: 38481660 PMC: 10933115. DOI: 10.3389/fcimb.2024.1297321.


Trypanosoma cruzi infection induces DNA double-strand breaks and activates DNA damage response pathway in host epithelial cells.

Gonzales-Cordova R, Dos Santos T, Gachet-Castro C, Andrade Vieira J, Trajano-Silva L, Sakamoto-Hojo E Sci Rep. 2024; 14(1):5225.

PMID: 38433244 PMC: 10909859. DOI: 10.1038/s41598-024-53589-w.


References
1.
Laderach D, Cerban F, Motran C, VOTTERO DE CIMA E, Gea S . Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII). Int J Parasitol. 1996; 26(11):1249-54. DOI: 10.1016/s0020-7519(96)00099-9. View

2.
Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, Cordeiro-da-Silva A . A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med. 2000; 6(8):890-7. DOI: 10.1038/78651. View

3.
Cunningham A, Gaspal F, Serre K, Mohr E, Henderson I, Scott-Tucker A . Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol. 2007; 178(10):6200-7. DOI: 10.4049/jimmunol.178.10.6200. View

4.
Sepulveda P, Hontebeyrie M, Liegeard P, Mascilli A, Norris K . DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect Immun. 2000; 68(9):4986-91. PMC: 101717. DOI: 10.1128/IAI.68.9.4986-4991.2000. View

5.
Fink K, Manjarrez-Orduno N, Schildknecht A, Weber J, Senn B, Zinkernagel R . B cell activation state-governed formation of germinal centers following viral infection. J Immunol. 2007; 179(9):5877-85. DOI: 10.4049/jimmunol.179.9.5877. View